Czech National Bank lifted its holdings in Danaher Co. (NYSE:DHR - Free Report) by 6.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 139,378 shares of the conglomerate's stock after acquiring an additional 8,439 shares during the period. Czech National Bank's holdings in Danaher were worth $31,994,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in DHR. Teachers Insurance & Annuity Association of America bought a new stake in shares of Danaher during the third quarter valued at approximately $39,000. MidAtlantic Capital Management Inc. bought a new stake in Danaher in the 3rd quarter valued at $40,000. FSA Wealth Management LLC purchased a new stake in Danaher in the 3rd quarter worth $50,000. Darwin Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter valued at about $55,000. Finally, Dunhill Financial LLC grew its position in shares of Danaher by 45.1% during the third quarter. Dunhill Financial LLC now owns 222 shares of the conglomerate's stock valued at $62,000 after purchasing an additional 69 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.
Analyst Upgrades and Downgrades
DHR has been the subject of several research reports. Royal Bank of Canada lowered their price objective on shares of Danaher from $333.00 to $311.00 and set an "outperform" rating for the company in a research report on Wednesday, October 23rd. Robert W. Baird dropped their price target on Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a research report on Wednesday, October 23rd. Bank of America upgraded Danaher from a "neutral" rating to a "buy" rating and set a $290.00 price objective on the stock in a research report on Friday, December 13th. KeyCorp lifted their target price on Danaher from $290.00 to $310.00 and gave the stock an "overweight" rating in a report on Wednesday, October 23rd. Finally, Scotiabank began coverage on Danaher in a report on Monday, December 23rd. They set a "sector perform" rating and a $265.00 price target on the stock. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $286.80.
Get Our Latest Stock Analysis on DHR
Danaher Stock Performance
Shares of DHR stock traded up $4.69 during mid-day trading on Monday, reaching $239.76. The stock had a trading volume of 1,904,782 shares, compared to its average volume of 2,718,638. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a 1-year low of $222.53 and a 1-year high of $281.70. The firm has a market cap of $173.17 billion, a price-to-earnings ratio of 45.76, a PEG ratio of 4.32 and a beta of 0.83. The business's fifty day moving average is $235.67 and its 200-day moving average is $253.73.
Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business's revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the business posted $2.02 EPS. On average, research analysts forecast that Danaher Co. will post 7.5 earnings per share for the current year.
Danaher Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be given a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. Danaher's dividend payout ratio is currently 20.61%.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.